NCT05156580 is a clinical trial of No intervention in Obesity, sponsored by Beijing Friendship Hospital.

Who is sponsoring NCT05156580?

NCT05156580 is sponsored by Beijing Friendship Hospital.

What drugs are being tested in NCT05156580?

Interventions in NCT05156580: No intervention.

What condition does NCT05156580 study?

NCT05156580 studies Obesity, Hypertension.

Is NCT05156580 still recruiting?

NCT05156580 is currently active, enrolled. Last updated 2 October 2025.

Last reviewed 2025-10-02 · How we verify

NCT05156580

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tongzhou Cohort Study

Active, enrolled Last updated 2 October 2025

What this trial tests

trial testing No intervention in Obesity in 31,080 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 July 2016

Primary endpoint
1 July 2026

1 September 2026

Quick facts

Lead sponsor	Beijing Friendship Hospital
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	31,080
Start date	1 July 2016
Primary completion	1 July 2026
Estimated completion	1 September 2026
Sites	1 location across China

Drugs / interventions tested

No intervention

Conditions studied

Obesity — all drugs for Obesity →
Hypertension — all drugs for Hypertension →

Sponsor

Beijing Friendship Hospital

Who can join

45 and older, any sex, with Obesity or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Long-term Impact of Overweight/Obesity and Hypertension on Cardiovascular Risk in Middle-aged and Elderly Adults

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Association between novel inflammatory markers and non-alcoholic fatty liver disease: a cross-sectional study.
Wang G, Zhao Y, Li Z, Li D, et al · · 2024 · cited 10× · PMID 38047735 · DOI 10.1097/meg.0000000000002686

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other Beijing Friendship Hospital trials

Trials by the same sponsor.

NCT07453862 — Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety · Phase 1 · recruiting
NCT07397442 — Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer · Phase 2 · not yet recruiting
NCT07393048 — Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant The · recruiting
NCT07441850 — Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy · NA · recruiting
NCT07369739 — Golidocitinib Combined With Selinexor for CAEBVD · Phase 2, PHASE3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05156580 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beijing Friendship Hospital
Last refreshed: 2 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05156580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing